Pompano Beach, FL, January 18, 2013 -- USA Graphite Inc (OTC: USGT) increased 0.60% to $0.85. Recently, the Company announced that it has already signed a letter of intent to purchase the Ruby Mountains Graphite Property, which has potential for high value flake graphite. The financial terms of the transaction consist of approximately $3,200,000 in cash and stock and a $500,000 work program commitment.
Will USGT Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here http://csrnewsdaily.com/c2/?company=USGT
Commerce Group Corp (PINKSHEETS: CGCO) is currently trading at $0.01.The 52-week range for the stock is $0.01 and $0.06. The 50-Day Moving Average and 200-Day Moving Average prices is $0.01 and $0.02 respectively. Commerce Group Corp is a precious metals company engaged in producing gold and silver in the Republic of El Salvador.
How Should Investors Trade CGCO After The Recent Momentum, Find Out Here http://csrnewsdaily.com/c2/?company=CGCO
Nano Labs Corp (OTC: CTLE) declined 1.56% to $0.63. The Company provided letter to shareholders regarding their road map and business plan for success through 2013. The Company focuses on the acquisition of coatings and laminates made from nanotechnology for its own use or licensing to others. The company was formerly known as Colorado Ceramic Tile Inc. and changed its name to Nano Labs Corp. in April 2012.
Get Free Special Trend Analysis On CTLE Here http://csrnewsdaily.com/c2/?company=CTLE
Southridge Enterprises Inc (PINKSHEETS: SRGE) declined 12.50% to $0.0014. So far this year, the stock is down over 71%. The 52-week range for the stock is $0.0 and $0.01. Southridge Minerals focuses on the acquisition, exploration, and development of gold and silver mines in Mexico.
Get Free Special Trend Analysis On SRGE Here http://csrnewsdaily.com/c2/?company=SRGE
AMARANTUS BIOSCI INC (OTC: AMBS) moved down 1.35% to $0.0878 on a traded volume of 167k shares. So far this year, the stock is down over 34%. The 52-week range for the stock is $0.0 and $0.19. The organization is a biotechnology company discovering and developing treatments and diagnostics for diseases associated with protein misfolding and apoptosis centered on its patented therapeutic protein Mesencephalic Astrocyte-derived Neurotrophic Factor.
Get Free Special Trend Analysis On AMBS Here http://csrnewsdaily.com/c2/?company=AMBS
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Pacific Dynasty Consultants Inc.
2637 E Atlantic Blvd #22611 Pompano Beach, FL 33062